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Oxidative Stress is Closely Related to
Clinical Severity of Preeclampsia
Oxidative stress in aerobic life can be defined as 
the imbalance between the generation of reactive
oxygen species (ROS) and the rate of their consump-
tion by antioxidants. In normal pregnancies, there 
is an increase in free radical production and lipoper-
oxidation towards the end of pregnancy when com-
pared with non-pregnant women.1 In a parallel
fashion, total antioxidant capacity (uric acid, vitamins
C and E, etc.) gradually increases during pregnancy,
leading to an oxidative balance maintained through-
out pregnancy.1
In preeclamptic women, lipoperoxidation prod-
ucts, especially malondialdehyde (MDA), increase,2
while enzymatic antioxidants superoxide dismutase
(SOD), glutathione peroxidase (GPx), and non-
enzymatic antioxidants (vitamins C and E) decrease.
During preeclampsia, levels of available nitric oxide
(NO) in plasma and placenta decrease, while an
increase in nitric oxide synthase (NOS) activity
occurs.3 The superoxide anion is known to inactivate
NO in a chemical reaction forming the potent free
radical peroxynitrite anion (ONOO−). The reaction
of NO with superoxide is 3 times faster than the rate
of reaction of O2 with SOD. When NO out-competes
SOD for O2, production of ONOO− is favored.
Peroxynitrite excess is responsible for the inflamma-
tion and nitration of tyrosine residues in proteins
(nitrotyrosine) and the increase of prostaglandin
synthesis as a product of the oxidation of arachidonic
acid in lipidic membranes, with a subsequent
blockage of vascular relaxation and increased smooth
muscle contracture, leading to the hypertensive
phenomena.1
Endothelial Cell Damage in Preeclampsia
In recent years, there has been increasing evidence
that free radicals may play a key role in and oxidative
stress may cause endothelial cell dysfunction in pre-
eclampsia.4 It was hypothesized that intermittent 
placental perfusion, secondary to deficient tropho-
blast invasion of the endometrial arteries, leads to an
ischemia–reperfusion-type insult and results in the
generation of free radicals.4 Free radicals attack free
fatty acids in cell membranes, and lipid hydroperox-
ides are formed. Consequently, lipid peroxides may
cause endothelial dysfunction and an increase in sen-
sitivity to vasopressors in preeclampsia.4 Free radical
production occurs continuously in all cells during
normal aerobic metabolism as part of normal cellular
function. However, cells have multiple protective mech-
anisms against oxidative stress. There is an equilibrium
between prooxidant and antioxidant systems in intact
cells.4 Imbalance favors prooxidants, which may lead
to cell and tissue damage in preeclampsia.4
Enzyme Activity of Basal Plasma
Membranes of Syncytiotrophoblast
from Normotensive and Preeclamptic
Pregnant Women
The Ca-ATPase activity of the plasma membranes 
of several tissues in preeclamptic pregnant women is
significantly reduced when compared with the corre-
sponding values in normotensive pregnant women.
These results give strong support to the hypothesis
that lowered Ca-ATPase activity described in the plasma
membranes of preeclamptic women is the consequence
of increased levels of lipid peroxidation.5 This condition
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has been considered to be the consequence of exten-
sive placental lipid peroxidation and failure of the
antioxidant protective mechanisms. Lipid produces
inhibition of membrane-bound enzymes that are
strongly dependent on the level of membrane lipid
peroxidation.5 Ca-ATPase is 1 of these enzymes. If the
plasma membrane of the syncytiotrophoblast is also
sensitive to the level of intracellular calcium, the
diminution of Ca-ATPase activity as a consequence of
a rise in lipid peroxidation of the plasma membrane
would lead to an increase in the level of intracellular
calcium, which would potentiate the level of lipid 
peroxidation of the plasma membrane and so forth. In
addition, lipid peroxidation products, such as MDA,
might raise the viscosity of the blood that is circulat-
ing through the placenta and contribute to increased
blood pressure.5
Endothelium-derived NO Released in
Arteries of Normal Pregnancies
The accumulation of oxidized low-density lipoprotein
(LDL) in vascular walls during atherogenesis impairs
vascular endothelial function. Normally, the vascular
endothelium prevents inappropriate adhesion of leuko-
cytes and platelets and vasospasm, in part through the
constitutive release of endothelium-derived NO.6
However, oxidized LDL impairs the release of NO
from normal arteries. This finding has been attributed
to the interruption of G protein-dependent stimulation
of NO release as well as to direct inactivation of NO by
lipid peroxidation products of oxidized LDL. Thus, in
the presence of oxidized LDL, the physiologic action
of NO is impaired, which might contribute to the
platelet adhesion and vasospasm that are involved in
the pathogenesis of acute coronary syndromes6 and in
preeclampsia.7
Oxidative Stress Also Affects 
the Newborn
Recently, it has been suggested that oxidative stress
might play a pivotal role in developmental processes
that later predispose to obesity, insulin resistance, and
glucose dysregulation.8 A variety of events that are
associated with poor fetal growth or preterm birth are
also associated with oxidative stress.6 These events
include maternal undernutrition and overnutrition,
infection, inflammation, and smoking, as well as con-
ditions such as gestational diabetes and gestational
hypertension.8 The oxidative stress theory suggests
that these stresses in the fetus lead to increased lipid
peroxidation, but more importantly, to modifications
in gene expression that lead to adverse perinatal pro-
gramming. The susceptibility of an individual fetus
will depend on the time during gestation when meta-
bolic programming occurs and on the genetic sus-
ceptibility of the fetus. Adiposity rebound, or an
increase in weight after initial slow growth and slow
early postnatal growth, has been implicated as a risk
factor for diabetes and as another explanation for the
increased metabolic risk for those with low birth
weight.8 The age at adiposity rebound may be associ-
ated with the risk of type 2 diabetes mellitus. The
increase in the prevalence of obesity may be related
not only to environmental circumstances but also to
epigenetic mechanisms that might have triggered the
phenomenon. The adverse intrauterine environment
could have a lasting effect on the fetus through
altered DNA methylation rates.
Increased Biological Oxidation and
Reduced Anti-oxidant Enzyme Activity
in Preeclamptic Placentae
Preeclampsia is a pregnancy-specific, multisystem dis-
order that can have considerable adverse effects on both
mother and fetus. More recently, antioxidants have
been proposed as a potential preventive strategy on
the basis of data suggesting that endothelial dysfunc-
tion is fundamental to the development of preeclamp-
sia and that increased oxidative stress, particularly in
the placenta, may contribute to endothelial dysfunc-
tion.9 Support for this concept comes from observa-
tions that markers of oxidative stress are increased and
endogenous antioxidant capacity is reduced in women
with preeclampsia.9 Although the magnitude of the
oxidative stress and of the reduction in antioxidant
activity in women with preeclampsia is the subject 
of considerable controversy, there has been interest in
the use of supplementation with vitamin C and vita-
min E to reduce oxidative stress, limit the injury to
endothelial cells, and prevent or reduce the severity of
preeclampsia.10
Limitation of the Use of Antioxidants 
in the Prevention of Preeclampsia
Until recently, the data supporting the efficacy of
supplementation with vitamin C and vitamin E for the
prevention of preeclampsia have been limited. Pub-
lished trials have focused on the use of antioxidants in
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pregnant women at high risk for developing preeclamp-
sia. In 1 randomized study involving 283 women at
high risk for preeclampsia on the basis of abnormal
uterine-artery Doppler waveforms or a history of the
disease, those receiving antioxidant therapy had a lower
rate of preeclampsia than did controls (8% vs. 17%),
and significant improvement in markers of endothelial
and placental function (ratio of plasminogen activator
inhibitors type 1 to type 2).10
The Maternal–Fetal Medicine Units Network of
the National Institute of Child Health and Human
Development is currently conducting in the United
States a multicenter trial of supplementation with vita-
min C and vitamin E for the prevention of preeclamp-
sia, with an anticipated sample of 10,000 low-risk
women.10 The data safety monitoring committee has
decided to continue this trial without modification after
reviewing the results provided by Poston et al.11 There
are also ongoing international trials of antioxidant ther-
apy to prevent preeclampsia, some involving women
in developing nations, where the intake of antioxidants
may be less and the benefit of supplementation may be
greater than in developed nations.10 Until more data
become available, given the scant evidence of benefit
and the potential for harm, supplemental antioxidant
therapy for the prevention of preeclampsia should not
be prescribed as part of routine practice.
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